Heightened risk for prostate cancer among balding males (redux)

Back in 2014, Zhou et al. reported an association between baldness and risk for diagnosis with aggressive forms of prostate cancer. At the time we noted that this association really needed to be confirmed in other studies. … READ MORE …

Just how real are the annual ACS estimates for risk associated with prostate cancer?

One has to be a very sophisticated statistician to understand how the American Cancer Society (ACS) comes up with its annual estimates for the numbers of people who will get diagnosed with and die of each specific form of cancer in any particular year. (And your sitemaster freely admits that he is not a sophisticated statistician.) … READ MORE …

Can a regular aspirin regimen extend survival of men with prostate cancer?

Another intriguing paper to be presented this week at the Genitourinary Cancers Symposium suggests an association between regular aspirin intake and risk for lethal prostate cancer among men already diagnosed with prostate cancer. … READ MORE …

Long-term survival of high-risk patients < 60 years of age treated by radical prostatectomy

A multi-institutional, international study has provided us with data on the 10-, 15-, and 20-year survival of a cohort of 600 relatively young, high-risk prostate cancer patients, all of whom were treated with first-line radical prostatectomy. … READ MORE …

Being happy doesn’t make women live longer!

A new paper just published in The Lancet concludes that “In middle-aged women, poor health can cause unhappiness” but that “happiness and related measures of wellbeing do not appear to have any direct effect on mortality” (at 10 years of follow-up). … READ MORE …

Targeting treatments for extraprostatic and oligometastatic prostate cancer with curative intent

The moderator of a well-known, prostate cancer-specific Internet forum recently wrote to us, stating,

There has been some assumption on the part of users of internet patient forums that the [newer and] more sensitive scans can be useful to detect major tumors that can be removed laparoscopically or treated with radiation, and that this would be beneficial.

… READ MORE …

Brachytherapy boost may lower mortality rate in high-risk patients

The ASCENDE-RT randomized clinical trial demonstrated that the combination of external beam radiation therapy with a brachytherapy boost (EBRT + BT) significantly reduced biochemical progression-free survival. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,367 other followers